Woodline Partners »

Cerevel Therapeutics Hldng I shares owned by Woodline Partners

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Woodline Partners

Quarter filed Position value Share count Share price at filing
2023-09-30 $10M 477k 21.83
2023-06-30 $25M 795k 31.79
2023-03-31 $15M 611k 24.39
2022-12-31 $15M 464k 31.54
2022-09-30 $15M 536k 28.26
2022-06-30 $6.8M 256k 26.44
2022-03-31 $13M 362k 35.01
2021-12-31 $7.7M 237k 32.42
2021-09-30 $5.8M 195k 29.50
2021-06-30 $3.7M 144k 25.62
2021-03-31 $5.4M 393k 13.73